Inflammation and angiogenesis in osteoarthritis.
OBJECTIVE
To quantify the relationship between inflammation and angiogenesis in synovial tissue from patients with osteoarthritis (OA).


METHODS
Hematoxylin and eosin staining and histologic grading for inflammation were performed for 104 patients who met the American College of Rheumatology criteria for OA and had undergone total joint replacement or arthroscopy. A purposive sample of synovial specimens obtained from 70 patients was used for further analysis. Vascular endothelium, endothelial cell (EC) proliferating nuclei, macrophages, and vascular endothelial growth factor (VEGF) were detected by immunohistochemical analysis. Angiogenesis (EC proliferation, EC fractional area), macrophage fractional area, and VEGF immunoreactivity were measured using computer-assisted image analysis. Double immunofluorescence histochemical analysis was used to determine the cellular localization of VEGF. Radiographic scores for joint space narrowing and osteophyte formation in the knee were also assessed.


RESULTS
Synovial tissue samples from 32 (31%) of 104 patients with OA showed severe inflammation; thickened intimal lining and associated lymphoid aggregates were often observed. The EC fractional area, EC proliferation, and VEGF immunoreactivity all increased with increasing histologic inflammation grade and increasing macrophage fractional area. In the synovial intimal lining, VEGF immunoreactivity was localized to macrophages and increased with increasing EC fractional area and angiogenesis. No inflammation or angiogenic indices were significantly correlated with radiographic scores.


CONCLUSIONS
Inflammation and angiogenesis in the synovium are associated with OA. The angiogenic growth factor VEGF generated by the inflamed synovium may promote angiogenesis, thereby contributing to inflammation in OA.
Haywood
L
L
University of Nottingham/City Hospital, Clinical Sciences Building, Hucknall Road, Nottingham NG5 1PB, UK.
McWilliams
D F
DF
Pearson
C I
CI
Gill
S E
SE
Ganesan
A
A
Wilson
D
D
Walsh
D A
DA
D000368:Aged; D016228:Endothelial Growth Factors / Q000032:analysis; D005260:Female; D006801:Humans; D036341:Intercellular Signaling Peptides and Proteins / Q000032:analysis; D008222:Lymphokines / Q000032:analysis; D008264:Macrophages / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009389:Neovascularization, Pathologic / Q000276:immunology* / Q000473:pathology / Q000503:physiopathology*; D015207:Osteoarthritis, Hip / Q000276:immunology* / Q000473:pathology / Q000503:physiopathology*; D020370:Osteoarthritis, Knee / Q000276:immunology* / Q000473:pathology / Q000503:physiopathology*; D013583:Synovial Membrane / Q000098:blood supply / Q000737:chemistry / Q000473:pathology; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
D016228:Endothelial Growth Factors; D036341:Intercellular Signaling Peptides and Proteins; D008222:Lymphokines; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors